Daniela Giannini

Daniela Giannini

Auto-generated profile, based on publicly available information

Daniela Giannini

IRCCS-Fondazione Bietti, Rome, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2010 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
VSViviana Scognamiglio
Viviana Scognamiglio
GEGianni Pezzotti Escobar
Gianni Pezzotti Escobar
IPIttalo Pezzotti
Ittalo Pezzotti
JCJuan Cano
Juan Cano
KBKatia Buonasera
Katia Buonasera
Maria Teresa GiardiMaria Teresa Giardi
Maria Teresa Giardi


18 March 2010 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
NGNorberto Mauricio Grzywacz
Norberto Mauricio Grzywacz
JJJoaquín de Juan
Joaquín de Juan
CFClaudia Ferrone
Claudia Ferrone
DGDaniela Giannini
Daniela Giannini
DHDavid Huang
David Huang
CBCarlo Bruni
Carlo Bruni
Optical coherence tomography (OCT) has recently become one of the primary methods for noninvasive probing of the human retina. The pseudoimage formed by OCT (the so-called B-scan) varies probabilistically across pixels due to complexities in the measurement technique. Hence, sensitive automatic procedures of diagnosis using OCT may exploit statistical analysis of the spatial distribution of reflectance. In this paper, we perform a statistical study of retinal OCT data. We find that the stretched exponential probability density function can model well the distribution of intensities in OCT pseudoimages. Moreover, we show a small, but significant correlation between neighbor pixels when measuring OCT intensities with pixels of about 5 ¿m. We then develop a simple joint probability model for the OCT data consistent with known retinal features. This model fits well the stretched exponential distribution of intensities and their spatial correlation. In normal retinas, fit parameters of this model are relatively constant along retinal layers, but varies across layers. However, in retinas with diabetic retinopathy, large spikes of parameter modulation interrupt the constancy within layers, exactly where pathologies are visible. We argue that these results give hope for improvement in statistical pathology-detection methods even when the disease is in its early stages.

10 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMarco Lombardo
Marco Lombardo
MPMariacristina Parravano
Mariacristina Parravano
SSSebastiano Serrao
Sebastiano Serrao
LZLucia Ziccardi
Lucia Ziccardi
DGDaniela Giannini
Daniela Giannini
GLGiuseppe Lombardo
Giuseppe Lombardo
To investigate a set of adaptive optics (AO) imaging biomarkers for the assessment of changes of the cone mosaic spatial arrangement in patients with type 1 diabetes mellitus (DM1). 16 patients with ≥20/20 visual acuity and a diagnosis of DM1 in the past 8 years to 37 years and 20 age-matched healthy volunteers were recruited in this study. Cone density, cone spacing and Voronoi diagrams were calculated on 160x160 μm images of the cone mosaic acquired with an AO flood illumination retinal camera at 1.5 degrees eccentricity from the fovea along all retinal meridians. From the cone spacing measures and Voronoi diagrams, the linear dispersion index (LDi) and the heterogeneity packing index (HPi) were computed respectively. Logistic regression analysis was conducted to discriminate DM1 patients without diabetic retinopathy from controls using the cone metrics as predictors. Of the 16 DM1 patients, eight had no signs of diabetic retinopathy (noDR) and eight had mild nonproliferative diabetic retinopathy (NPDR) on fundoscopy. On average, cone density, LDi and HPi values were significantly different (P<0.05) between noDR or NPDR eyes and controls, with these differences increasing with duration of diabetes. However, each cone metric alone was not sufficiently sensitive to discriminate entirely between membership of noDR cases and controls. The complementary use of all the three cone metrics in the logistic regression model gained 100% accuracy to identify noDR cases with respect to controls. The present set of AO imaging biomarkers identified reliably abnormalities in the spatial arrangement of the parafoveal cones in DM1 patients, even when no signs of diabetic retinopathy were seen on fundoscopy.

27 September 2019 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
MAMassimo Accorinti
Massimo Accorinti
MGMarta Gilardi
Marta Gilardi
DGDaniele De Geronimo
Daniele De Geronimo
LILudovico Iannetti
Ludovico Iannetti
DGDaniela Giannini
Daniela Giannini
MPMariacristina Parravano
Mariacristina Parravano
Purpose: To study macular microvascular changes in ocular Behçet disease (OBD) using optical coherence tomography angiography (OCTA). Methods: Quantitative and qualitative analyses of OCTA were performed on 23 OBD patients with active or inactive uveitis and compared with healthy controls. Results: Deep capillary plexus (DCP) is the most frequently involved in OBD (p < 0.001). Its vessel density (VD) is reduced compared with controls in both active (p < 0.007) and inactive uveitis (p = 0.03). In inactive uveitis, VD is inversely related to the number of uveitis relapses (superficial capillary plexus: r = –0.694, p = 0.004; DCP: r = –0.541, p = 0.037) and it is significantly reduced in patients with a uveitis-free period ≥5 years compared with healthy controls (p < 0.038). Conclusions: Macular VD is reduced in Behçet patients with active and inactive uveitis, especially in DCP. In inactive uveitis, VD is inversely related to the number of ocular relapses and cannot be restored during time.

16 March 2020 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
MPMariacristina Parravano
Mariacristina Parravano
FSFabio Scarinci
Fabio Scarinci
VPVincenzo Parisi
Vincenzo Parisi
PGPaola Giorno
Paola Giorno
DGDaniela Giannini
Daniela Giannini
MVMonica Varano
Monica Varano
Introduction This study aimed to evaluate the effect of treatment with eye drops containing citicoline and vitamin B12 on changes in function of the inner retina, morphology of the inner and outer retina, and microvascular condition in patients with type 1 diabetes (DM1) with mild signs of non-proliferative diabetic retinopathy (NPDR) during 3 years of follow-up. Methods A pilot study with prospective, randomized, and double-masked design was conducted to address the aims. Twenty patients with DM1 were enrolled and randomly divided into two groups: the DC group comprising patients treated with citicoline and vitamin B12 eye drops (10 patients; mean age ± standard deviation, 46.86 ± 8.78 years) and the DP group comprising those treated with placebo (10 patients; mean age ± standard deviation, 47.89 ± 7.74 years). In the DC group, one eye of each patient was treated with citicoline and vitamin B12 eye drops (OMK2®, Omikron Italia srl, Italy, 3 drops/day), while in the DP group, it was treated with placebo (eye drops containing hypromellose 0.3%, 3 drops/day) for a 3-year period. In both groups, Humphrey Matrix frequency doubling technology (FDT), spectral domain optical coherence tomography (SD-OCT) and OCT angiography (OCTA), and adaptive optics (AO) were applied at baseline and 12, 24, and 36 months of the follow-up period. Results In the results of follow-up evaluation, the DC and DP groups were significantly different: Significant reduction in function in terms of 10-2 FDT mean sensitivity and in morphology reflected by an increase in inner nuclear layer thickness and decrease in other plexiform layer thickness and foveal vessel density were observed in the DP group, while no such significant changes were observed in the DC group in the long term. Conclusions This pilot study indicated that patients with DM1 with mild signs of diabetic retinopathy (DR) who underwent treatment with citicoline and vitamin B12 eye drops for a 3-year duration achieved stabilization or decreased rate of functional impairment, neuroretinal degeneration, and microvascular damage. Trial Registration ClinicalTrials.gov identifier, NCT04009980.